ECM Weekly (9 Nov 2019) - Phoenix Tree, I-Mab, Tyro Payments, Pharmaron, Heaven-Sent
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Hong Kong...
900 Views
SinoMab (中国抗体) IPO - A Hard Sell
SinoMab is a Hong Kong-based biotech company with a focus on mAb-based biologics for the treatment of immunological diseases, launched its book...
655 Views
SinoMab (中国抗体): Pipeline Concentrated on Autoimmune Therapy
SinoMab, the first Hong Kong-headquartered biotech company coming to list on the SEHK, plans to raise USD100 to 200 million. In this insight, we...
975 Views